![](https://endpts.com/wp-content/uploads/2023/01/John-Rim-Samsung-Biologics-feature.jpg)
John Rim, Samsung Biologics president and CEO
Samsung Biologics secures $400M+ manufacturing deal with Pfizer
Samsung Biologics struck a deal with Pfizer to manufacture the drugmaker’s biosimilars portfolio, including its products for immunology, inflammation and oncology, the South Korean company …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.